PT - JOURNAL ARTICLE AU - Olson, Jenny L. AU - Castillo, Gisell AU - Palumbo, Amelia AU - Harrison, Megan AU - Singleton, Ruth AU - Lalu, Manoj M. AU - Fergusson, Dean A. AU - Stintzi, Alain AU - Mack, David R. AU - Presseau, Justin TI - A qualitative evaluation of treatment fidelity alongside a pilot trial of a novel therapy for pediatric IBD AID - 10.1101/2023.09.27.23296250 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.27.23296250 4099 - http://medrxiv.org/content/early/2023/09/28/2023.09.27.23296250.short 4100 - http://medrxiv.org/content/early/2023/09/28/2023.09.27.23296250.full AB - Background Process evaluations conducted alongside clinical trials can improve understanding of treatment fidelity and provide contextual knowledge to aide interpretations of trial outcomes. We adopted a multiple-goals perspective to investigate treatment fidelity in two related pilot clinical trials of an adjuvant treatment for pediatric-onset Inflammatory Bowel Disease. This included a focus on barriers and enablers of performing trial-specific activities and of integrating those activities into daily life.Methods We interviewed a sub-sample of participants of the Resistant Starch in Pediatric Inflammatory Bowel Disease (NCT04522271) and Optimized Resistant Starch in Inflammatory Bowel Disease pilot trials (NCT04520594) and their caregivers (N=42). The trials examined the effects of personalized food-derived resistant starches as an adjuvant therapy on intestinal microbiome functioning. Codes were identified inductively though conventional content analysis and then mapped to personal projects units of analysis, to explore how participants navigated between activities.Results Three themes were identified. The first described the potential impact of living with inflammatory bowel disease and taking prescribed medications. The second described characteristics of trial-specific activities that might impact on their enactment, including perceived difficulty, and challenges following procedures or using trial materials. The third described the integration of trial-specific activities with school, work, household demands, and social, and extracurricular activities.Conclusions Adjusting to living with inflammatory bowel disease and managing its treatment can impact trial participation. Integrating trial-related activities into daily life can be challenging, which could heighten perceptions of goal conflict. Findings can inform interpretations of trial outcomes and development of strategies for trial optimization and implementation of the adjuvant therapy into clinical practice.Competing Interest StatementAS and DM are co-founders of MedBiome, a clinical microbiomics company. The other authors have no competing interests to declare.Clinical TrialNCT0452227 NCT04520594Clinical Protocols https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-021-00815-1 Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has received ethics approval from the Children’s Hospital of Eastern Ontario Research Ethics Board (ID # 20/65X).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData cannot be shared publicly because of the risk of identification of individual participants. De-identified data will be made available upon reasonable request to the corresponding author.